Curasight (CURAS) Investor Update summary

Rights issue details

• Subscription period for Curasight's rights issue runs from 2 May to 16 May 2025, with trading in subscription rights from 30 April to 14 May 2025.

• Each existing share as of 1 May 2025 grants 43 subscription rights; 18 rights are needed to subscribe for one new share at DKK 1.98.

• Full subscription would raise approximately DKK 100 million before transaction costs.

• Subscription and guarantee commitments cover about DKK 47 million, or 47% of the total rights issue.

• Outcome of the rights issue is expected to be published on 21 May 2025.

Legal and regulatory information

• No prospectus will be prepared; an information document is available on Curasight's website, prepared under EU regulations.

• The rights issue is only available to the public in Denmark and Sweden; in other EEA states, only qualified investors may participate.

• Distribution of the announcement is restricted in several jurisdictions, including the US, Canada, and others.

• The Danish Financial Supervisory Authority has not approved or reviewed the disclosure document.

• Forward-looking statements are included and subject to risks and uncertainties.

Advisors and contacts

• Sedermera Corporate Finance AB acts as sole global coordinator and bookrunner; DLA Piper is legal advisor; Danske Bank A/S is settlement agent.

• Contact details for further information are provided for both Sedermera and Curasight's CEO.